<bill session="115" type="h" number="6133" updated="2019-07-16T21:20:08Z">
  <state datetime="2018-06-19">REFERRED</state>
  <status>
    <introduced datetime="2018-06-19"/>
  </status>
  <introduced datetime="2018-06-19"/>
  <titles>
    <title type="official" as="introduced">To deter opioid abuse and addiction through the development of high-quality, evidence-based opioid analgesic prescribing guidelines, and for other purposes.</title>
    <title type="short" as="introduced">Informing Opioid Prescribing Through Evidence-Based Guidelines Act of 2018</title>
    <title type="short" as="introduced">Informing Opioid Prescribing Through Evidence-Based Guidelines Act of 2018</title>
    <title type="display">Informing Opioid Prescribing Through Evidence-Based Guidelines Act of 2018</title>
  </titles>
  <sponsor bioguide_id="M001187"/>
  <cosponsors/>
  <actions>
    <action datetime="2018-06-19">
      <text>Introduced in House</text>
    </action>
    <action datetime="2018-06-19" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="HSIF" name="House Energy and Commerce" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill type="h" session="115" relation="unknown" number="6"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Administrative law and regulatory procedures"/>
    <term name="Congressional oversight"/>
    <term name="Department of Health and Human Services"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Drug therapy"/>
    <term name="Drug trafficking and controlled substances"/>
    <term name="Food and Drug Administration (FDA)"/>
    <term name="Government studies and investigations"/>
    <term name="Health care costs and insurance"/>
    <term name="Health care coverage and access"/>
    <term name="Health promotion and preventive care"/>
    <term name="Prescription drugs"/>
    <term name="Public participation and lobbying"/>
    <term name="Retail and wholesale trades"/>
  </subjects>
  <amendments/>
  <summary date="2018-06-19T04:00:00Z" status="Introduced in House">Informing Opioid Prescribing Through Evidence-Based Guidelines Act of 2018

This bill requires the Food and Drug Administration to develop evidence-based opioid prescribing guidelines for certain acute pain treatment.</summary>
  <committee-reports/>
</bill>
